Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-14-010099

CFO & COO acquired 189,624 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CULPEPPER PETER R CFO & COO 2014-02-26 Option exercise +68,624 $1.10 $75,486 1,012,332 D: show line 1 in the form
CULPEPPER PETER R CFO & COO 2014-02-26 Option exercise +121,000 $1.10 $133,100 121,000 I: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CULPEPPER PETER R CFO & COO 2014-02-26 Option exercise · Stock Option (right to buy) +189,624 0 D: show line 3 in the form
Loading xslF345X03/doc1.xml…